...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Annual and Special Mtg & Corporate Update Presentation 12/22/20 - Rough Transcript

Just for info,,,,,,,this compnay was trading last evening at $1.65......today announces,,!!!! drum roll!!!!

This afternoons close,,,$2.07,,what does this management team know that ZCC management does not?

 

Listing would provide access to the United States market and position Company to accelerate its business strategy

VANCOUVER, British Columbia, Jan. 11, 2021 -- via InvestorWire – PlantX Life Inc. (the “ Company ” or “ PlantX ”) (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) is pleased to announce today that it has taken a significant step to enhance its investor profile by launching a new capital markets strategy focused on the United States (“U.S.”). As a result, the Company has applied to list its common shares on the NASDAQ Capital Market (“NASDAQ”).

 

Share
New Message
Please login to post a reply